Hydration Pharmaceuticals Co Ltd
ASX:HPC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.009
0.026
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Hydration Pharmaceuticals Co Ltd
Cost of Revenue
Hydration Pharmaceuticals Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hydration Pharmaceuticals Co Ltd
ASX:HPC
|
Cost of Revenue
-$4.6m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Bioxyne Ltd
ASX:BXN
|
Cost of Revenue
-AU$5.9m
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-17%
|
|
|
McPherson's Ltd
ASX:MCP
|
Cost of Revenue
-AU$68.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Star Combo Pharma Ltd
ASX:S66
|
Cost of Revenue
-AU$20.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Elixinol Wellness Ltd
ASX:EXL
|
Cost of Revenue
-AU$4.8m
|
CAGR 3-Years
17%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
B
|
Biome Australia Ltd
ASX:BIO
|
Cost of Revenue
-AU$5.1m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
-97%
|
CAGR 10-Years
N/A
|
|
Hydration Pharmaceuticals Co Ltd
Glance View
The Hydration Pharmaceuticals Co. Ltd. markets and sells a range of liquid, tablet and powder healthy hydration solutions products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-12-14. The firm markets and sells a range of liquid, tablet, and powder Hydration solutions products in North American markets of Canada and the United States, under the Hydralyte brand. The company operates in three segments of the healthy hydration solutions market, consisting of over the counter (OTC) consumer healthcare market, functional beverages market, and vitamin and mineral supplements (VMS) market. Digestive health and paediatric diarrhoea remedies is contained within the OTC Consumer Healthcare market. The Oral Rehydration Solutions market and Functional Beverages market is focused on providing oral rehydration solutions to help replenish important salts and fluids lost. Health and wellness hydration solutions consist in the Vitamin and Mineral Supplements (VMS) market. The VMS market segment offers rehydration with vitamins and minerals in a liquid format.
See Also
What is Hydration Pharmaceuticals Co Ltd's Cost of Revenue?
Cost of Revenue
-4.6m
USD
Based on the financial report for Dec 31, 2023, Hydration Pharmaceuticals Co Ltd's Cost of Revenue amounts to -4.6m USD.
What is Hydration Pharmaceuticals Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-2%
Over the last year, the Cost of Revenue growth was -6%. The average annual Cost of Revenue growth rates for Hydration Pharmaceuticals Co Ltd have been -24% over the past three years , -2% over the past five years .
You don't have any saved screeners yet